Sunshine Biopharma Inc. (SBFM) Insider Ownership

Historic Ownership Trends

There are no significant Insider Shareholders in Sunshine Biopharma as of January 02, 2026.

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares Report Date
Abderrazzak Merzouki Chief Operating Officer 0 16 Feb, 2021
Camille Sebaaly Cfo/Secretary 4 01 Dec, 2022
Steve N. Slilaty Chief Executive Officer 3 05 Mar, 2024

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
04 Mar, 2024 Steve N. Slilaty Series B Preferred Stock A 100,000 $0.10 3 D P
08 Feb, 2024 Steve N. Slilaty Series B Preferred Stock A 20,000 $0.10 1 D P
30 Nov, 2022 Camille Sebaaly - - 4 D
30 Nov, 2022 Camille Sebaaly Common Stock A 30,000 $0.76 4 D P
03 Jun, 2022 Camille Sebaaly Common Stock A 25,000 $1.22 4 D P
18 Feb, 2022 Steve N. Slilaty Series B Preferred Stock D 990,000 $0.10 0 D D
18 Feb, 2022 Steve N. Slilaty - - 0 D
06 Jan, 2021 Camille Sebaaly Common Stock A 20,000,000 $0.00 0 D A
06 Jan, 2021 Steve N. Slilaty Common Stock A 20,000,000 $0.00 0 D A
06 Jan, 2021 Abderrazzak Merzouki Common Stock A 20,000,000 $0.00 0 D A
06 Jan, 2021 Camille Sebaaly - - 0 D
17 Jun, 2020 Steve N. Slilaty Series "B" Preferred Stock A 500,000 $0.10 0 D A
02 Sep, 2019 Steve N. Slilaty Common Stock A 13,000,000 $0.00 0 D A
02 Sep, 2019 Camille Sebaaly Common Stock A 13,000,000 $0.00 0 D A
11 Sep, 2019 Camille Sebaaly - - 0 D
11 Sep, 2019 Camille Sebaaly Common Stock A 11,000,000 $0.00 0 D A
27 Aug, 2018 Camille Sebaaly Common Stock A 38,000,000 $0.00 0 D A
27 Aug, 2018 Steve N. Slilaty Common Stock A 38,000,000 $0.00 0 D A
27 Aug, 2018 Abderrazzak Merzouki Common Stock A 38,000,000 $0.00 0 D A
20 Jun, 2018 Steve N. Slilaty Common Stock A 27,000,000 $0.00 0 D A